The Sp1 family of transcription factors is involved in p27Kip1-mediated activation of myelin basic protein gene expression

Molecular and Cellular Biology

Volumn 23, Issue 12, 2003, Pages 4035-4045

  Wei, Qiou ^a   Miskimins, W Keith ^a   Miskimins, Robin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MYELIN BASIC PROTEIN; PROTEIN P27; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DELETION MUTANT; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROMOTER REGION; RAT; WESTERN BLOTTING;

ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYELIN BASIC PROTEINS; OLIGODENDROGLIA; PLASMIDS; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; SP1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0037980189     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.12.4035-4045.2003     Document Type: Article

References (40)

1. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Aoyama, A., T. A. Tamura, and K. Mikoshiba. 1990. Regulation of brain-specific transcription of the mouse myelin basic protein gene: function of the NFI-binding site in the distal promoter. Biochem. Biophys. Res. Commun. 167:648-653.
3. Apt, D., R. M. Watts, G. Suske, and H. U. Bernard. 1996. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology 224:281-291.
4. Armstrong, S. A., D. A. Barry, R. W. Leggett, and C. R. Mueller. 1997. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272:13489-13495.
5. Black A. R., D. Jensen, S. Y. Lin, and J. C. Azizkhan. 1999. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 274:1207-1215.
6. Boussiotis, V. A., G. J. Freeman, P. A. Taylor, A. Berezovskaya, I. Grass, B. R. Blazar, and L. M. Nadler. 2000. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6:290-297.
7. Busse, D., R. S. Doughty, T. T. Ramsey, W. E. Russell, J. O. Price, W. M. Flanagan, L. K. Shawver, and C. L. Arteaga. 2000. Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity. J. Biol. Chem. 275:6987-6995.
8. Cook, T., B. Gebelein, and R. Urrutia. 1999. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann. N. Y. Acad. Sci. 880:94-102.
9. Deleu, L., F. Fuks, D. Spitkovsky, R. Horlein, S. Faisst, and J. Rommelaere. 1998. Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP-overexpressing cells versus serum-starved or growing cells. Mol. Cell. Biol. 18:409-419.
10. Deschenes, C., A. Vezina, J. F. Beaulieu, and N. Rivard. 2001. Role of p27(Kip1) in human intestinal cell differentiation. Gastroenterology 120: 423-438.
11. Durand, B., Gao, F. B., and Raff, M. C. 1997. Accumulation of the cyclindependent kinase inhibitor p27/kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16:306-317.
12. Ekholm, S. V. a. R., S.I. 2000. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12:676-684.
13. Espinosa de los Monteros, A., P. Zhao, C. Huang, T. Pan, R. Chang, R. Nazarian, D. Espejo, and J. de Vellis. 1997. Transplantation of CG4. oligodendrocyte progenitor cells in the myelin-deficient rat brain results in myelination of axons and enhanced oligodendroglial markers. J. Neurosci. Res. 50:872-887.
14. Fojas de Borja, P., N. K. Collins, P. Du, J. Azizkhan-Clifford, and M. Mudryj. 2001. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 20:5737-5747.
15. Ghiani, C., and V. Gallo. 2001. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J. Neurosci. 21:1274-1282.
16. Ghiani, C. A., A. M. Eisen, X. Yuan, R. A. DePinho, C. J. McBain, and V. Gallo. 1999. Neurotransmitter receptor activation triggers p27(Kip1) and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development 126:1077-1090.
17. Han, I., and J. E. Kudlow. 1997. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17:2550-2558.
18. Hauser, P. J., D. Agrawal, M. Flanagan, and W. J. Pledger. 1997. The role of p27kip1 in the in vitro differentiation of murine keratinocytes. Cell Growth Differ. 8:203-211.
19. Jackson, S. P., J. J. MacDonald, S. Lees-Miller, and R. Tjian. 1990. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63:155-165.
20. Katayose, Y., M. Kim, A. N. Rakkar, Z. Li, K. H. Cowan, and P. Seth. 1997. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res. 57:5441-5445.
21. Louis, J. C., E. Magal, D. Muir, M. Manthorpe, and S. Varon. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31:193-204.
22. Miskimins, R., R. Srinivasan, M. Marin-Husstege, W. K. Miskimins, and P. Casaccia-Bonnefil. 2002. p27Kipl p27 Kip 1 enhances myelin basic protein gene promoter activity. J. Neurosci. Res. 67:100-105.
23. Mitsuhashi, T., Y. Aoki, Y. Z. Eksioglu, T. Takahashi, P. G. Bhide, S. A. Reeves, and V. S. Caviness, Jr. 2001. Overexpression of p27Kip1 lengthens the G1 phase in a mouse model that targets inducible gene expression to central nervous system progenitor cells. Proc. Natl. Acad. Sci. USA 98:6435-6440.
24. Mortensen, E. R., P. A. Marks, A. Shiotani, and J. L. Merchant. 1997. Epidermal growth factor and okadaic acid stimulate Sp1 proteolysis. J. Biol. Chem. 272:16540-16547.
25. Nakayama, K. 1998. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 20:1020-1029.
26. Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480.
27. Nishinaka, T., Y. H. Fu, L. I. Chen, K. Yokoyama, and R. Chiu. 1997. A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1. Biochim. Biophys. Acta 1351:274-286.
28. Quaroni, A., J. Q. Tian, P. Setb, and C. Ap Rhys. 2000. p27(Kip1) is an inducer of intestinal epithelial cell differentiation. Am. J. Physiol. Cell Physiol. 279:C1045-C1057.
29. Rank, K. B., D. B. Evans, and S. K. Sharma. 2000. The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase. Biochem. Biophys. Res. Commun. 271:469-473.
30. Rohlff, C., S. Ahmad, F. Borellini, J. Lei, and R. I. Glazer. 1997. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 272:21137-21141.
31. Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massague, and N. P. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
32. Sasaki, K., S. Tamura, H. Tachibana, M. Sugita, Y. Gao, J. Furuyama, E. Kakishita, T. Sakai, T. Tamaoki, and T. Hashimoto-Tamaoki. 2000. Expression and role of p27(kip1) in neuronal differentiation of embryonal carcinoma cells. Brain Res. Mol. Brain Res. 77:209-221.
33. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
34. Su, K., X. Yang, M. D. Roos, A. J. Paterson, and J. E. Kudlow. 2000. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem. J. 348:281-289.
35. Suske, G. 1999. The Sp-family of transcription factors. Gene 238:291-300.
36. Tang, X. M., J. S. Beesley, J. B. Grinspan, P. Seth, J. Kamholz, and F. Cambi. 1999. Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendrocyte differentiation. J. Cell. Biochem. 76: 270-279.
37. Tikoo, R., P. Casaccia-Bonnefil, M. V. Chao, and A. Koff. 1997. Changes in cyclin-dependent kinase 2 and p27kip1 accompany glial cell differentiation of central glia-4 cells. J. Biol. Chem. 272:442-447.
38. Tikoo, R., D. J. Osterhout, P. Casaccia-Bonnefil, P. Seth, A. Koff, and M. V. Chao. 1998. Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest. J. Neurobiol. 36:431-440.
39. Tretiakova, A., A. Steplewski, E. M. Johnson, K. Khalili, and S. Amini. 1999. Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. J. Cell. Physiol. 181:160-168.
40. Vidal, A., and A. Koff. 2000. Cell-cycle inhibitors: three families united by a common cause. Gene 247:1-15.